Advanced Identity Authentication Technologies Could Prove a

New Post Public Reply Private Reply Replies (0) Message Board
Roger Wilco
Advanced Identity Authentication Technologies Could Prove a Boon for Shares of NXTD


http://www.baystreet.ca/articles/stockstowatch.aspx?id=682

There’s a Wocket in My Pocket! may soon not just be a sentence from the mouths of children after reading the rhyming book by Dr. Seuss. There was plenty of made-up ridiculousness in the iconic book, such as a bofa on the sofa, but there is nothing fictitious about the Wocket, a next-generation payment and identity product that is being developed by Shelton, Connecticut-based NXT-ID, Inc. (OTCQB:NXTD).

NXT-ID was founded by former senior management at Technest Holdings and its subsidiary, Genex Technologies, industry-leading companies in the field of advanced imaging, including 3D and 360-degree technologies. NXT-ID has licensed these companies’ technologies, as well as technologies from 3D-imaging expert Geometrix. Utilizing these technologies with their own intellectual property, NXT-ID is launching MobileBio, a technology that secures consumers’ mobile platforms through authentication and encryption.

As the trend continues to move towards mobile transactions, there is a great need for advanced solutions to protect users’ and institutions’ information more effectively than the inherently insecure standards of payment today. MobileBio is the cornerstone of NXT-ID’s end-to-end solutions to bridge the gap.

The company has developed Biocloud, a cloud-based biometric identify authentication solution for consumer applications and corporate security. The company’s MobileBio Voicematch platform can be bootstrapped to several platforms, such as smartphones, tablets and
computers, to embed additional security via voice recognition biometrics to ensure the identity of a user before allowing access to countless applications. Voicematch is forecast to be available in the first quarter of 2014.

Along the same lines, MobileBio Facematch employs modular facial recognition to devices for superior authentication and encryption. Several configurations are possible, including hosting the technology on a device or remotely in the cloud by marrying
Facematch with Biocloud. According to NXT-ID, Facematch will soon be available in an app for iPhone and Android systems.

After Thursday’s closing bell, NXT-ID announced that it took the next step with its next-generation digital wallet, called the "Wocket." The Wocket is being designed to reduce the number of cards in a person’s wallet while supporting essentially every payment method used today at retailers, such as magnetic stripe, barcodes, etc. all from a secure digital vault. The company said that it has successfully ported its MobileBio voicematch algorithm to the Wocket, which brings the product one move closer to commercialization.

"We are pleased with the continued development of the Wocket™," says David Tunnell, CTO of NXT-ID. "Our approach eliminates the need for passwords by authenticating identity in a natural way for users. With Voicematch™, users can simply ask for a user-defined name of a card and the Wocket™ then automatically programs the NXTCard with the card of their choice."

A lot of noise has been made recently about improving security on devices of all types. Apple (NASDAQ:AAPL) was even criticized for not including their thumbprint technology on the latest generation of iPhones 5C’s to prevent unauthorized use. While thumbprint technology is certainly a more advanced security feature and will be welcomed by the masses, what NXT-ID is taking things to the next level with voice and facial recognition. In short (and layman’s terms), this is some pretty cool stuff.

NXT-ID is an early-stage company that just went public in August via an S-1 registration, but interest seems to remain strong with shares climbing from initially around $1.50 to as high as $6.00 before pulling back to current levels around $3.50. As the products start rolling-out to the public, even more investors (and other companies) may start taking note of this upstart and the cutting-edge technology it possesses. Proper due diligence is, as always, encouraged.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 11

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 17

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 22

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 20

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 23

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into Stella-Jones Conference Call for Q3 Results

Updated Category News Views 70

Upcoming Conference Call for Stella-Jones Inc. Stella-Jones Inc. (TSX: SJ), a prominent player in the manufacturing of pressure-treated wood products, is set to hold a significant conference call to discuss its third quarter results. Details of the Conference Call The conference call is open to investors, analysts, and all interested parties. It will take place on...

Continue Reading
Total Voting Rights Announcement for Northern Venture Trust

Updated Category News Views 75

Update on Total Voting Rights Northern Venture Trust PLC has released a key update concerning its total voting rights. In line with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, the Company is informing the market about its present capital structure. Overview of Ordinary Shares As per the latest information, Northern Venture Trust PLC's...

Continue Reading
Northrop Grumman Faces Investor Scrutiny Amid Financial Decline

Updated Category News Views 431

Investor Concerns Around Northrop Grumman Investors holding shares in Northrop Grumman Corporation (NYSE: NOC) are facing critical developments as they are encouraged to evaluate their positions in light of recent financial disclosures and ongoing investigations by legal entities. This alert revolves around Northrop Grumman's recent performance and future implications...

Continue Reading
Nature's Sunshine Welcomes Katie May to Board Leadership

Updated Category News Views 420

Nature's Sunshine Embraces New Leadership with Katie A. May Nature's Sunshine Products, Inc. is thrilled to announce that Katie A. May has joined its board of directors, marking a significant step in enhancing leadership and direction within the company. With a rich background in ecommerce and logistics, Katie's new role reflects the company's commitment to further...

Continue Reading
NewAmsterdam Pharma Announces Participation in Key Investor Conferences

Updated Category News Views 79

NewAmsterdam Pharma to Attend Investor Conferences NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is a leading biopharmaceutical firm committed to creating innovative oral medications designed to reduce low-density lipoprotein (LDL) cholesterol levels for individuals at risk of cardiovascular disease (CVD). The company is preparing for a series of upcoming investor...

Continue Reading